Naxicap-backed Moria Surgical, a manufacturer and distributor of high precision instruments, agreed to acquire Alchimia, an Italian player in retina surgery and keratoplasty. Financial terms were not disclosed. "We are delighted to welcome the Alchimia team to our group. This acquisition allows Moria to rapidly expand its product offering in a market where surgeons’ needs are constantly and rapidly evolving. The acquisition of Alchimia also represents an excellent commercial opportunity," Bruno Chermette, Moria Chairman and CEO.